Clinical trial
Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)
NCT02268981 is registered in ClinicalTrials.gov with Schön Klinik Berchtesgadener Land as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)
- Lead sponsor
- Schön Klinik Berchtesgadener Land
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- September 30, 2015
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.